Opinion

Yakup Ergün: The policy of some journals to collect accepted letters under a single heading is quite unfair

Yakup Ergün/obdh.com.tr

May 26, 2024, 10:50

Yakup Ergün: The policy of some journals to collect accepted letters under a single heading is quite unfair

Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared on X:

“The policy of some journals (especially those in the LANCET group) to collect accepted letters under a single heading is quite unfair. Clinical trial articles are usually written by writing teams supported by industry sponsors and often bring together many researchers. In contrast, letters are usually the effort of one or a few independent researchers trying to make their voices heard on their own. At the very least, they should respect this effort and publish the letters under the titles chosen by the authors. I believe this would be fairer. This way, the intended message does not get lost under a general heading. Letters are not worthless. They strengthen articles by providing different perspectives.”

Yakup Ergün

Source: Yakup Ergün/X
.

Ankara Numune Training and Research Hospital cancer clinical trial articles independent researchers industry sponsors journals LANCET group letters medical oncologist OncoDaily Oncology policy Yakup Ergün

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer